PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RXST vs. SLNO
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RXST and SLNO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

RXST vs. SLNO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in RxSight, Inc. (RXST) and Soleno Therapeutics, Inc. (SLNO). The values are adjusted to include any dividend payments, if applicable.

100.00%150.00%200.00%250.00%300.00%JulyAugustSeptemberOctoberNovemberDecember
110.37%
230.99%
RXST
SLNO

Key characteristics

Sharpe Ratio

RXST:

-0.22

SLNO:

0.45

Sortino Ratio

RXST:

0.05

SLNO:

1.06

Omega Ratio

RXST:

1.01

SLNO:

1.12

Calmar Ratio

RXST:

-0.25

SLNO:

0.27

Martin Ratio

RXST:

-0.63

SLNO:

1.91

Ulcer Index

RXST:

18.57%

SLNO:

13.36%

Daily Std Dev

RXST:

54.56%

SLNO:

57.06%

Max Drawdown

RXST:

-48.21%

SLNO:

-99.86%

Current Drawdown

RXST:

-47.64%

SLNO:

-93.12%

Fundamentals

Market Cap

RXST:

$1.53B

SLNO:

$2.07B

EPS

RXST:

-$0.81

SLNO:

-$2.79

Total Revenue (TTM)

RXST:

$138.39M

SLNO:

$3.45M

Gross Profit (TTM)

RXST:

$87.81M

SLNO:

$1.97M

EBITDA (TTM)

RXST:

-$26.47M

SLNO:

-$136.50M

Returns By Period

In the year-to-date period, RXST achieves a -16.52% return, which is significantly lower than SLNO's 12.25% return.


RXST

YTD

-16.52%

1M

-24.88%

6M

-40.68%

1Y

-13.25%

5Y*

N/A

10Y*

N/A

SLNO

YTD

12.25%

1M

-17.30%

6M

9.79%

1Y

19.24%

5Y*

6.79%

10Y*

-9.77%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RXST vs. SLNO - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RXST, currently valued at -0.22, compared to the broader market-4.00-2.000.002.00-0.220.45
The chart of Sortino ratio for RXST, currently valued at 0.05, compared to the broader market-4.00-2.000.002.004.000.051.06
The chart of Omega ratio for RXST, currently valued at 1.01, compared to the broader market0.501.001.502.001.011.12
The chart of Calmar ratio for RXST, currently valued at -0.25, compared to the broader market0.002.004.006.00-0.250.88
The chart of Martin ratio for RXST, currently valued at -0.63, compared to the broader market-5.000.005.0010.0015.0020.0025.00-0.631.91
RXST
SLNO

The current RXST Sharpe Ratio is -0.22, which is lower than the SLNO Sharpe Ratio of 0.45. The chart below compares the historical Sharpe Ratios of RXST and SLNO, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.502.002.503.00JulyAugustSeptemberOctoberNovemberDecember
-0.22
0.45
RXST
SLNO

Dividends

RXST vs. SLNO - Dividend Comparison

Neither RXST nor SLNO has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RXST vs. SLNO - Drawdown Comparison

The maximum RXST drawdown since its inception was -48.21%, smaller than the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for RXST and SLNO. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-47.64%
-23.66%
RXST
SLNO

Volatility

RXST vs. SLNO - Volatility Comparison

RxSight, Inc. (RXST) has a higher volatility of 18.42% compared to Soleno Therapeutics, Inc. (SLNO) at 12.79%. This indicates that RXST's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%JulyAugustSeptemberOctoberNovemberDecember
18.42%
12.79%
RXST
SLNO

Financials

RXST vs. SLNO - Financials Comparison

This section allows you to compare key financial metrics between RxSight, Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab